Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TAS1440 |
Synonyms | |
Therapy Description |
TAS1440 binds to and inhibits the lysine-specific demethylase LSD1, which may lead to inhibition of cell growth in tumor cells with LSD1 overexpression (NCI Thesaurus). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TAS1440 | TAS 1440|TAS-1440 | KDM1A Inhibitor 15 | TAS1440 binds to and inhibits the lysine-specific demethylase LSD1, which may lead to inhibition of cell growth in tumor cells with LSD1 overexpression (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04282668 | Phase I | TAS1440 + Tretinoin TAS1440 | A Study of TAS1440 With ATRA in Subjects With r/r AML | Active, not recruiting | USA | 0 |